Literature DB >> 18250464

Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo.

Khaled Ali1, Montserrat Camps, Wayne P Pearce, Hong Ji, Thomas Rückle, Nicolas Kuehn, Christian Pasquali, Christian Chabert, Christian Rommel, Bart Vanhaesebroeck.   

Abstract

The leukocyte-enriched p110gamma and p110delta isoforms of PI3K have been shown to control in vitro degranulation of mast cells induced by cross-linking of the high affinity receptor of IgE (FcepsilonRI). However, the relative contribution of these PI3K isoforms in IgE-dependent allergic responses in vivo is controversial. A side-by-side comparative analysis of the role of p110gamma and p110delta in mast cell function, using genetic approaches and newly developed isoform-selective pharmacologic inhibitors, confirms that both PI3K isoforms play an important role in FcepsilonRI-activated mast cell degranulation in vitro. In vivo, however, only p110delta was found to be required for optimal IgE/Ag-dependent hypersensitivity responses in mice. These observations identify p110delta as a key therapeutic target among PI3K isoforms for allergy- and mast cell-related diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250464      PMCID: PMC2643005          DOI: 10.4049/jimmunol.180.4.2538

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.

Authors:  Lei Bi; Ichiro Okabe; David J Bernard; Robert L Nussbaum
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

Review 2.  Mast cells and basophils in acquired immunity.

Authors:  J Wedemeyer; S J Galli
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

Review 3.  PI3K in lymphocyte development, differentiation and activation.

Authors:  Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

4.  Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement.

Authors:  Chanchal Sadhu; Boris Masinovsky; Ken Dick; C Gregory Sowell; Donald E Staunton
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

5.  Essential role for Gab2 in the allergic response.

Authors:  H Gu; K Saito; L D Klaman; J Shen; T Fleming; Y Wang; J C Pratt; G Lin; B Lim; J P Kinet; B G Neel
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

Review 6.  Integrated signalling pathways for mast-cell activation.

Authors:  Alasdair M Gilfillan; Christine Tkaczyk
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

7.  Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function.

Authors:  Muriel Laffargue; Ronan Calvez; Peter Finan; Alexandre Trifilieff; Maryse Barbier; Fiorella Altruda; Emilio Hirsch; Matthias P Wymann
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

Review 8.  Synthesis and function of 3-phosphorylated inositol lipids.

Authors:  B Vanhaesebroeck; S J Leevers; K Ahmadi; J Timms; R Katso; P C Driscoll; R Woscholski; P J Parker; M D Waterfield
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

9.  Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Authors:  Klaus Okkenhaug; Antonio Bilancio; Géraldine Farjot; Helen Priddle; Sara Sancho; Emma Peskett; Wayne Pearce; Stephen E Meek; Ashreena Salpekar; Michael D Waterfield; Andrew J H Smith; Bart Vanhaesebroeck
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

10.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

View more
  44 in total

1.  The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.

Authors:  Molly S Thomas; Jason S Mitchell; Christopher C DeNucci; Amanda L Martin; Yoji Shimizu
Journal:  J Leukoc Biol       Date:  2008-06-03       Impact factor: 4.962

Review 2.  Class I PI3K in oncogenic cellular transformation.

Authors:  L Zhao; P K Vogt
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 3.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

4.  Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases.

Authors:  Montse Erra; Joan Taltavull; Angelique Gréco; Francisco Javier Bernal; Juan Francisco Caturla; Jordi Gràcia; María Domínguez; Mar Sabaté; Stéphane Paris; Salomé Soria; Begoña Hernández; Clara Armengol; Judit Cabedo; Mónica Bravo; Elena Calama; Montserrat Miralpeix; Martin D Lehner
Journal:  ACS Med Chem Lett       Date:  2016-11-30       Impact factor: 4.345

5.  Inhibition of PI3Kδ improves systemic lupus in mice.

Authors:  Yanxia Wang; Lei Zhang; Ping Wei; Huailiang Zhang; Cuijie Liu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 6.  PI3-kinase inhibitors in chronic lymphocytic leukemia.

Authors:  Julie E Chang; Brad S Kahl
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

7.  The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.

Authors:  K Balakrishnan; M Peluso; M Fu; N Y Rosin; J A Burger; W G Wierda; M J Keating; K Faia; S O'Brien; J L Kutok; V Gandhi
Journal:  Leukemia       Date:  2015-04-28       Impact factor: 11.528

8.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.

Authors:  Dalya R Soond; Elisa Bjørgo; Kristine Moltu; Verity Q Dale; Daniel T Patton; Knut Martin Torgersen; Fiona Galleway; Breda Twomey; Jonathan Clark; J S Hill Gaston; Kjetil Taskén; Peter Bunyard; Klaus Okkenhaug
Journal:  Blood       Date:  2010-01-15       Impact factor: 22.113

9.  Phosphoinositide 3-Kinase δ Regulates Dectin-2 Signaling and the Generation of Th2 and Th17 Immunity.

Authors:  Min Jung Lee; Eri Yoshimoto; Shinobu Saijo; Yoichiro Iwakura; Xin Lin; Howard R Katz; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 10.  PI 3-kinase and cancer: changing accents.

Authors:  Peter K Vogt; Marco Gymnopoulos; Jonathan R Hart
Journal:  Curr Opin Genet Dev       Date:  2009-02       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.